| Product Information |
|
| Registration Number |
BR-1148
|
| Generic Name |
Combined Diphtheria, Tetanus, Acellular Pertussis Vaccine, Adsorbed
|
| Brand Name |
Boostrix
|
| Dosage Strength |
Formulation: 1 dose (0.5 mL) contains:
Diphtheria toxoid*-Not less than 2 IU (2.5Lf) Tetanus toxoid*-Not less than 20 IU (5Lf) Pertussis toxoid (PT)*-8mcg Filamentous Hemagglutinin (FHA)*-8mcg Pertactin-2.5mcg *adsorbed on Aluminum hydroxide, hydrated (Al(OH)3)-300 mcg Al3 and Aluminum phosphate (AlPO4)-200 mcg A13+
|
| Dosage Form |
Suspension For Injection (I.M.)
|
| Classification |
Prescription Drug (RX)
|
| Packaging |
0.5 mL Suspension in Type I Glass Vial with Gray Butyl Rubber Stopper and Flip-off Cap (Box of 10's)
|
| Pharmacologic Category |
Vaccine
|
| Manufacturer |
GlaxoSmithKline Biologicals SA
|
| Country of Origin |
Belgium
|
| Trader |
N/A
|
| Importer |
GlaxoSmithKline Philippines, Inc.
|
| Distributor |
N/A
|
| Application Type |
Renewal
|
| Issuance Date |
27 April 2021
|
| Expiry Date |
03 June 2026
|